Werewolf Therapeutics, Inc. Share Price
NASDAQ: HOWL | Micro CapWerewolf Therapeutics, Inc. Stock Performance
Werewolf Therapeutics, Inc. Share Price Today
As of 30 October 2026, Werewolf Therapeutics, Inc.'s share price is $1.09. The stock opened at $1.09, compared to its previous close of $1.07. During today's trading session, Werewolf Therapeutics, Inc.'s share price traded between $1.07 and $1.10, with an average price of $1.08. Over the past 52 weeks, the stock has recorded a high of $1.61 and a low of $0.28. In terms of performance, Werewolf Therapeutics, Inc.'s share price has risen by 47.10% over the last six months and is down 16.48% on a year-on-year basis.
Werewolf Therapeutics, Inc. Share Price Chart
Werewolf Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Werewolf Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Werewolf Therapeutics, Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.
Werewolf Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $0.93 | $1.09 | +17.84% |
Sep 2026 | $0.92 | $0.93 | -4.05% |
Aug 2026 | $0.37 | $0.96 | +173.09% |
Jul 2026 | $0.36 | $0.35 | -1.12% |
Jun 2026 | $0.46 | $0.36 | -20.67% |
May 2026 | $0.74 | $0.45 | -39.27% |
Apr 2026 | $0.87 | $0.74 | -12.31% |
Mar 2026 | $0.57 | $0.84 | +40.13% |
Feb 2026 | $0.68 | $0.60 | -12.48% |
Jan 2026 | $0.63 | $0.69 | +9.37% |
Dec 2025 | $0.97 | $0.63 | -37.62% |
Nov 2025 | $1.32 | $1.01 | -22.61% |